Laboratory Test Information Guide

Details for Mitochondrial Genome Sequencing and Depletions/Integrity Pane

Test Name: Mitochondrial Genome Sequencing and Depletions/Integrity Pane
Alternate Name(s): mtDNA sequencing
LHON
MELAS
MERF
Laboratory: Molecular Diagnostics
Specimen Type: Whole blood-2 x 4 mL Lavender EDTA top Vacutainer tube
Collection Information: Sample may be transported at room temperature. Alternative tissues may be accepted after consult with laboratory.
Requisition: REQUISITION FOR DNA TESTING-MOLECULAR GENETICS LABORATORY
Test Schedule:  
Turnaround time from when specimen
is received in testing laboratory:
 
Routine
42 days
Stat
 
 
Reference Range:  
Effective Date: 2018-11-01
Revised Date:  
Critical Value:  
Interpretive Comments: The human mitochondrial DNA (mtDNA) encodes 37 genes coding for two rRNAs, 22 tRNAs and 13 polypeptides within its 16 569 bp. The mtDNA-encoded polypeptides are all subunits of enzyme complexes of the oxidative phosphorylation system. Disease phenotypes resulting from mitochondrial mutations may appear as distinct syndromes, such as Kearns-Sayre syndrome (KSS), Leberís Hereditary Optic Neuropathy (LHON), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), chronic progressive external ophthalmoplegia (CPEO), myoclonic epilepsy with ragged-red fibers (MERRF), neurogenic weakness with ataxia and retinitis pigmentosa (NARP) or Leigh syndrome (LS). More frequently, the clinical presentation is much more heterogeneous. Some common symptoms include ptosis, external ophthalmoplegia, proximal myopathy, exercise intolerance, cardiomyopathy, sensorineural deafness, migraine, stroke-like episodes, pigmentary retinopathy, diabetes mellitus, encephalopathy, seizures, ataxia, and spasticity. This panel has been augmented with a selected series of 19 nuclear genes known to be associated the mitochondrial depletion disorders. About 80-95% of patients with mitochondrial disorders do not harbor a pathogenic mutation in the mitochondrial genome. A large proportion of these cases may have defects in nuclear-encoded genes that are involved in the biosynthesis of the mitochondrial genome or in the maintenance of mtDNA integrity. The Mitochondrial Genome Sequencing and Depletion/Integrity panel is appropriate for patients suspected of having one of the various forms of mtDNA depletion syndrome and/or mtDNA multiple deletions.
Special Processing:  
Comments: Test cost covered by MOHLTC for Ontario residents with OHIP coverage.
Method of Analysis: Next Generation Sequencing (NGS)
Critical Information Required:  
Storage & Shipment: Samples may be stored and shipped at room temperature
System Codes: 
Cerner
MD Mitochondrial Panel
 
Referred To:  

Questions? Comments? Contact Laura Gopaul